GleamWall
中文EN

IQV IQVIA HOLDINGS INC.

Services-Commercial Physical & Biological Research · NYSE · SEC CIK 1478242 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.8%
TTM net income YoY8.7%
TTM EPS YoY13.1%
Revenue 3-yr CAGR5.2%
Net income 3-yr CAGR7.7%

Margins

Gross margin33.1%
Operating margin12.8%
Net margin8.1%
FCF margin12.0%
EBITDA margin19.9%

Returns

ROE21.7%
ROA4.7%
ROIC (approx.)9.3%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets77.7%
Debt / equity2.41x
Current ratio0.83x
Interest coverage2.83x

Cash quality & payout

Operating cash flow / net income1.96x
Accruals ratio-4.5%
Payout ratio—
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$16.31B$15.40B
Cost of revenue$10.88B$10.03B
Gross profit$5.43B$5.38B
SG&A expense$2.00B$1.99B
Operating income$2.18B$2.20B
Interest expense$729.00M$670.00M
Pretax income$1.59B$1.67B
Income tax$252.00M$301.00M
Net income$1.36B$1.37B
EBITDA$3.33B$3.32B
EPS (basic)7.917.57
EPS (diluted)7.847.49
Weighted avg. shares (diluted)173.50M183.40M
Balance sheet
Cash & equivalents$1.98B$1.70B
Short-term investments$161.00M$141.00M
Receivables$3.40B$3.20B
Current assets$6.25B$5.83B
PP&E, net$533.00M$535.00M
Goodwill$16.62B$14.71B
Intangibles$4.96B$4.50B
Total assets$29.94B$26.90B
Current liabilities$8.34B$6.96B
Short-term debt$1.84B$1.15B
Long-term debt$13.88B$12.84B
Total debt$15.72B$13.98B
Total liabilities$23.31B$20.83B
Shareholders' equity$6.50B$6.07B
Net debt$13.74B$12.28B
Shares outstanding169.60M176.10M
Cash flow statement
Operating cash flow$2.65B$2.72B
Capital expenditure$603.00M$602.00M
Free cash flow$2.05B$2.11B
Investing cash flow-$2.31B-$1.44B
Financing cash flow-$150.00M-$878.00M
Depreciation & amortization$1.14B$1.11B
Stock-based compensation$247.00M$206.00M
Share buybacks$1.24B$1.35B

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.